News
Drug prices in the United States are astronomical and climbing. Many analysts blame mergers and acquisitions among ...
Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...
Eli Lilly (LLY) stock in focus as the company beats Biogen (BIIB) to win regulatory nod in Australia for first ...
The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the largest gift in its history.
Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...
Major pharmaceutical manufacturing company Eli Lilly is considering a $5.7 billion investment into a facility in Houston.
Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results